TrialJournal for immunotherapy of cancer2019

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.

Marit M Melssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.